Compugen (CGEN) Current Deferred Revenue (2009 - 2026)
Compugen (CGEN) reported Current Deferred Revenue of $11.6 million for Q1 2026, up 20.49% on a YoY basis from $9.6 million in Q1 2025, and up 5.72% sequentially from $11.0 million in Q4 2025.
Compugen (CGEN) Current Deferred Revenue (2009 - 2026) Analysis & Trends
Compugen (CGEN) has 10 years of Current Deferred Revenue data on file, last reported at $11.6 million in Q1 2026.
- For the quarter ending Q1 2026, Current Deferred Revenue rose 20.49% year-over-year to $11.6 million; the trailing twelve-month figure through Mar 2026 stood at $11.6 million (up 20.49% YoY), and the FY2025 full-year result was $11.0 million, up 13.89% from the prior year.
- Current Deferred Revenue improved to $11.6 million in Q1 2026, from $11.0 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $29.6 million in Q2 2025 to a low of $9.6 million in Q1 2025.
- A 4-year average of $13.1 million and a median of $11.1 million in 2023 frame the typical range for Current Deferred Revenue.
- Peak annual rise in Current Deferred Revenue reached 162.99% in 2025, while the deepest fall reached 32.92% in 2025.
- Tracing CGEN's Current Deferred Revenue over 4 years: stood at $11.1 million in 2023, then decreased by 13.61% to $9.6 million in 2024, then climbed by 13.89% to $11.0 million in 2025, then gained by 5.72% to $11.6 million in 2026.
- Business Quant data shows CGEN's Current Deferred Revenue at $11.6 million in Q1 2026, $11.0 million in Q4 2025, and $10.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.60 Mn |
| Dec 31, 2025 | 10.97 Mn |
| Sep 30, 2025 | 10.68 Mn |
| Jun 30, 2025 | 29.59 Mn |
| Mar 31, 2025 | 9.63 Mn |
| Dec 31, 2024 | 9.63 Mn |
| Sep 30, 2024 | 15.91 Mn |
| Jun 30, 2024 | 11.25 Mn |
| Mar 31, 2024 | 10.76 Mn |
| Dec 31, 2023 | 11.15 Mn |
| Sep 30, 2016 | 53,000.00 |
| Jun 30, 2016 | 123,000.00 |
| Mar 31, 2016 | 219,000.00 |
| Dec 31, 2015 | 312,000.00 |
| Sep 30, 2015 | 824,000.00 |
| Jun 30, 2015 | 1.05 Mn |
| Mar 31, 2015 | 1.28 Mn |
| Dec 31, 2014 | 1.79 Mn |
| Sep 30, 2014 | 2.02 Mn |
| Jun 30, 2014 | 3.12 Mn |